Pagalaran, Rosemy J.

HRN: 28-88-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/13/2026
05/19/2026
IV
900mg
Q24
CAP HR
Checking Initial Appropriateness 

 Indication:  EmpiricEmpirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines